Activity

Filter

Cancel
Date Panel Item Activity
8 actions
Inherited pancreatic cancer v2.9 ATM Achchuthan Shanmugasundram Tag Q2_24_promote_green was removed from gene: ATM.
Tag Q2_24_MOI was removed from gene: ATM.
Tag Q2_24_NHS_review was removed from gene: ATM.
Inherited pancreatic cancer v2.9 ATM Achchuthan Shanmugasundram reviewed gene: ATM: Rating: GREEN; Mode of pathogenicity: ; Publications: ; Phenotypes: ; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Inherited pancreatic cancer v2.8 ATM Achchuthan Shanmugasundram Source NHS GMS was added to ATM.
Source Expert Review Green was added to ATM.
Rating Changed from Amber List (moderate evidence) to Green List (high evidence)
Inherited pancreatic cancer v2.4 ATM Sarah Leigh reviewed gene: ATM: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: ; Mode of inheritance: None
Inherited pancreatic cancer v2.4 ATM Sarah Leigh Tag Q2_24_promote_green tag was added to gene: ATM.
Tag Q2_24_MOI tag was added to gene: ATM.
Tag Q2_24_NHS_review tag was added to gene: ATM.
Inherited pancreatic cancer v2.4 ATM Sarah Leigh Classified gene: ATM as Amber List (moderate evidence)
Inherited pancreatic cancer v2.4 ATM Sarah Leigh Gene: atm has been classified as Amber List (Moderate Evidence).
Inherited pancreatic cancer v2.3 ATM Terri McVeigh gene: ATM was added
gene: ATM was added to Inherited pancreatic cancer. Sources: Other
Mode of inheritance for gene: ATM was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Publications for gene: ATM were set to 34529012; 33509806
Phenotypes for gene: ATM were set to Breast, prostate, pancreatic cancer predisposition; recessive trait for ataxia telangiectasia
Penetrance for gene: ATM were set to Incomplete
Mode of pathogenicity for gene: ATM was set to Other
Review for gene: ATM was set to GREEN
Added comment: Discussed at UKCGG/Cancer Leads meeting 29th February 2024 - consensus that ATM should be added to this panel for diagnostic testing in individuals with pancreatic cancer fulfilling eligibility criteria. Reporting of variants should be restricted to truncating variants, high-risk missense c.7271T/G and exceptional variants as determined by Can-VIG UK, as per other panels where ATM is tested for cancer predisposition (R208/430)
Sources: Other